Jeffrey Kent

Jeffrey Kent is a member of the project management team at the DPS Group in Boston, with a proven track record of delivering complex biopharm projects in both process engineering and project management roles. Jeff has a strong background in traditional mAB bioprocesses stemming from roles in manufacturing purification at Biogen Idec and R&D at Genzyme Corp focussing on cell culture. Most recently Jeff has been executing capital design projects for clients seeking flexible platforms for mRNA, viral vectors, gene therapy and cell therapy. Jeff is a Chemical Engineering graduate of Queens University in Canada and holds an M.Eng. in Chemical Engineering from Northeastern University.